文献速递自身炎症与 IgG4 相关病

滤泡外Tph2样细胞主导的组织病理型与IgG4相关病复发相关

Extrafollicular Tph2-like cell dominant tissue pathotype is associated with relapse in IgG4-related disease.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

中位随访150周期间19例(25.7%)复发,复发组基线Tph2细胞更高、CD19+ B细胞更低,泪腺T-B病理型与更高复发率相关,并在独立验证队列中重现。

要点

  • 基线血Tph2细胞升高与CD19+ B细胞降低是IgG4-RD复发的独立预测因素。
  • 泪腺活检T-B病理型(滤泡外CX3CR1+ Tph2样细胞聚集、B细胞浸润低)与更高复发率相关。
  • 激素剂量、减量速度及联用免疫抑制剂在复发与非复发组间无差异。

核心结论

  • 血Tph2细胞升高、CD19+ B细胞降低及泪腺T-B病理型可能与IgG4-RD复发风险增加相关。

研究设计与样本

  • 泪腺活检标本用自动化图像定量分为T-B病理型或B病理型,并用独立临床队列验证。

主要发现

  • 中位随访150周,19例(25.7%)复发。
  • 复发组基线Tph2细胞中位数1.8 vs 0.9 cells/μl(P = 0.018),CD19+ B细胞中位数82 vs 133 cells/µl(P = 0.002)。
  • 多变量分析确定Tph2细胞和CD19+ B细胞为复发的独立预测因素。
  • 泪腺T-B病理型与更高复发率相关(P = 0.022),并在独立验证集中重现。

关键数值与推荐

  • 泪腺活检T-B病理型定义为滤泡外区域CX3CR1+ Tph2样细胞积聚伴相对低B细胞浸润。
  • 复发组与非复发组的糖皮质激素剂量、减量速度及联用免疫抑制剂无差异。

临床怎么用

  • 对IgG4-RD患者在缓解诱导治疗前可检测血Tph2细胞和CD19+ B细胞以辅助识别高复发风险者。
  • 泪腺活检组织分型为T-B病理型提示复发风险较高,可考虑加强随访。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Relapse is common in IgG4-related disease (IgG4-RD), but reliable predictors to identify high-risk patients remain limited. We sought to identify blood and tissue immune features at the initiation of remission induction therapy associated with subsequent relapse. METHODS: Seventy-four consecutive, active patients with IgG4-RD were prospectively enrolled in a cohort, and comprehensive immunophenotyping of 64 blood immune subsets was performed. They were followed after remission induction therapy until relapse or last visit. Lacrimal gland biopsy specimens were analysed using automated image-based quantification to classify tissues as T-B-pathotype or B-pathotype. An independent clinical cohort was used as a validation set. RESULTS: During a median follow-up of 150 weeks, 19 patients (25.7%) relapsed. Glucocorticoid dose, tapering speed, and concomitant immunosuppressive use did not differ between relapse and non-relapse groups. The numbers of Tph2 cells were higher (median 1.8 vs 0.9 cells/μl, P = 0.018) and CD19+ B cells were lower (median 82 vs 133 cells/µl, P = 0.002) in the relapse group compared with the non-relapse group at baseline. Multivariable analysis identified Tph2 cells and CD19+ B cells as the independent predictors of relapse. This peripheral immune profile was mirrored in affected tissues, where CX3CR1+ Tph2-like cells accumulated in extrafollicular regions of lacrimal glands with relatively low B cell infiltration (T-B-pathotype). In lacrimal gland biopsies, T-B-pathotype was associated with a higher relapse rate (P = 0.022), findings reproduced in an independent validation set. CONCLUSION: Higher Tph2 cells and lower CD19+ B cells in blood and T-B-pathotype in lacrimal glands are potentially associated with increased relapse risk in IgG4-RD.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Shimanuki K, Akiyama M, Saito K, et al. Extrafollicular Tph2-like cell dominant tissue pathotype is associated with relapse in IgG4-related disease. Rheumatology (Oxford). 2026. PMID: 42587431. doi:10.1093/rheumatology/keag417

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。